Accretion Nutraveda IPO GMP & Subscription Status: Day 1 IPO Live Updates

The Accretion Nutraveda IPO GMP is ₹0 as of 22nd January 2026. It is a book-building issue IPO of ₹24.77 crores. This is an entirely fresh issue of 0.19 crore shares. The issue will be listed on BSE and SME on its tentative listing date, 30th January 2026. The face value of Accretion Nutraveda IPO shares is ₹10 per share, and the IPO price band is ₹122 to ₹129 per share. Retail investors can bid for a minimum of 2 lots of 2,000 shares worth ₹2,58,000. Scroll down to check the Accretion Nutraveda IPO GMP and subscription details.

Accretion Nutraveda IPO GMP Grey Market Premium

As mentioned earlier, the Accretion Nutraveda IPO GMP currently stands at ₹0.00 per share. Thus, the estimated listing price would be at ₹70.00. This indicates that the estimated listing gain in this IPO could be 0.00%. Explore the table for Accretion Nutraveda IPO GMP updates.

Note: GMP details are subject to change based on market conditions and fluctuations. Check the live Accretion Nutraveda IPO GMP status at Univest.

Click and Sign Up to Get Live Updates on Accretion Nutraveda IPO GMP Status

Accretion Nutraveda IPO Subscription Status

As of now, the Accretion Nutraveda IPO has been subscribed to 0.01 times. Of these, 0.02 times are subscribed by retail investors, 0.01 times by non-institutional investors, and 0.00 times by QII (Qualified Institutional Investors).  

The healthy subscription status indicates that investors are expecting higher returns at the time of Accretion Nutraveda’s IPO listing on 4th February 2026. Accretion Nutraveda also has a positive outlook behind the fresh issue of 0.19 crore shares, which will raise around Rs 24.77 crores.

Note: GMP details are subject to change based on market conditions and fluctuations. Check the live Accretion Nutraveda IPO Subscription status at Univest.

Click and Sign Up to Get Live Updates on Accretion Nutraveda IPO Subscription Status

Accretion Nutraveda IPO Details

Also Read: Accretion Nutraveda IPO GMP & Review: Apply or Avoid?

Explanation

Accretion Nutraveda IPO: Accretion Nutraveda IPO Limited has declared an issue price band of ₹122 to ₹129 per share. With this IPO, the company allows retail investors to bid for at least 2 lots of 2,000 shares, each worth ₹2,58,000. The face value of Accretion Nutraveda IPO Limited shares is ₹10 per share. The shares of Accretion Nutraveda IPO Limited will be listed on BSE and SME on its tentative listing day, 4th February 2026. Scroll down to check GMP updates and Accretion Nutraveda IPO reviews. 

About Accretion Nutraveda Ltd.

Accretion Nutraveda Limited was established in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products in various dosage forms, including tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels The company operates as a Contract Development and Manufacturing Organization (CDMO), serving both domestic and international markets such as Sri Lanka, Singapore, and the USA. Its products combine classical Ayurvedic principles with modern nutraceutical science to address areas like liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness.

Business verticals:

1. Domestic Sales & Merchant Exports (Loan License Basis)– contributing 96.62% of total revenue in FY 2024-25.
2. Direct Exports– Contributing 38%, showing consistent growth.

It has a manufacturing facility in Gujarat that covers about 10,763 sq. ft., equipped with modern infrastructure, including 13 air handling units, separate processing areas, and quality control systems. The facility is GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal certified, with an FSSAI license.

Also Read- Accretion Nutraveda IPO GMP & Review: Apply or Avoid?

Accretion Nutraveda Limited Financials

The company’s financial analysis is essential before applying for the Accretion Nutraveda IPO. Look at the table to learn about Accretion Nutraveda Limited’s financials. 

Explanation

Accretion Nutraveda Limited’s revenue increased by 208.84% from ₹5.20 crores in March 2024 to ₹16.06 crores in March 2025. Moreover, the company’s PAT increased by 218.29% from ₹0.82 crores in March 2024 to ₹2.61 crores in March 2025.

Accretion Nutraveda IPO Objectives

The primary aim of the Accretion Nutraveda IPO is to raise ₹24.77 crores. On the other hand, Accretion Nutraveda has decided to utilise these funds in different ways.

• To purchase machinery for Automation in the existing Manufacturing unit
• To Purchase Machinery for the New Manufacturing Setup
• To General Corporate Expenses.
• To fund the working capital requirements of our company

Accretion Nutraveda IPO Registrar

Kfin Technologies Limited is the registrar for the Accretion Nutraveda IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Accretion Nutraveda allotment and refund, you can contact Kfin Technologies Limited at apl.ipo@kfintech.com or at 04067162222, 04079611000.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces! 

Accretion Nutraveda IPO Review

The Accretion Nutraveda IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Accretion Nutraveda Limited’s revenue increased by 208.84% from ₹5.20 crores in March 2024 to ₹16.06 crores in March 2025. Moreover, the company’s PAT increased by 218.29% from ₹0.82 crores in March 2024 to ₹2.61 crores in March 2025.

Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Accretion Nutraveda IPO or not.

The P/E ratio of Accretion Nutraveda Limited shares is 26.27, and its Earnings Per Share (EPS) stands at 4.91. Thus, the Accretion Nutraveda IPO can deliver gains on its tentative listing date, 4th February 2026. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Accretion Nutraveda Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

FAQs on Accretion Nutraveda IPO

What is the Accretion Nutraveda IPO GMP?

Currently, on 28th January 2026, the Accretion Nutraveda IPO GMP (Grey Market Premium) stands at ₹0. This indicates that the estimated listing price could be ₹129.00 per share.

What is the issue price of the Accretion Nutraveda IPO?

The Accretion Nutraveda IPO issue price band is set at ₹122.00 to ₹129.00 per share. Retail investors can apply for a minimum of 2 lots, each consisting of 2,000 shares, worth ₹2,58,000. Moreover, HNIs are required to bid for a minimum of 3 lots (3,000 shares) worth ₹3,87,000.

Who is the registrar of the Accretion Nutraveda IPO?

Kfin Technologies Limited is the registrar for the Accretion Nutraveda IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Accretion Nutraveda allotment and refund, you can contact Kfin Technologies Limited at apl.ipo@kfintech.com or at 04067162222, 04079611000.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Accretion Nutraveda IPO, download the Accretion Nutraveda IPO RHP and Accretion Nutraveda IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Recent Articles

Kanishk Aluminium India IPO GMP & Review: Apply or Avoid?

Msafe Equipments IPO GMP & Review: Apply or Avoid?

Union Budget 2026: What to Expect

The Indian Cements Q3 Results 2026 Highlights: Net Profit Falls by 102.18% & Revenue Up 18.56% YoY

Shriram Finance Q3 Results 2026 Highlights: Net Profit Falls by 22.09% & Revenue Up 13.76% YoY

CSB Bank Gears Up for Q3 Reveal on 28th January; Check Key Expectations Here